Astrocytomas and oligodendrogliomas represent one third of histologically confirmed canine brain tumors. Our purpose was to describe the magnetic resonance (MR) imaging features of histologically confirmed canine intracranial astrocytomas and oligodendrogliomas and to examine for MR features that differentiate these tumor types.
astrocytomas, 12/16 oligodendrogliomas). For astrocytomas and oligodendrogliomas, respectively, common findings were contrast enhancement (10/13, 11/15), ring-like contrast enhancement (6/10, 9/11), cystic regions within the mass (7/14, 12/16) , and hemorrhage (4/14, 6/16). Oligodendrogliomas were significantly more likely to contact the brain surface (meninges) than astrocytomas (14/16, 7/14, respectively, P = 0.046). Contact with the lateral ventricle was the most common finding, occurring in 13/14 astrocytomas and 14/16 oligodendrogliomas. No MR features were identified that reliably distinguished between these two tumor types. Contrast enhancement was more common in high grade tumors (III or IV) than low grade tumors (II, P = 0.008).
Introduction
Astrocytomas and oligodendrogliomas are glial tumors and account for 31% of primary brain tumors in dogs. 1 The World Health Organization (WHO) recognizes low and high grade variants of astrocytoma (e.g., diffuse astrocytoma (II), anaplastic astrocytoma (III), glioblastoma multiforme (IV)) and oligodendrogliomas (e.g., oligodendroglioma (II), anaplastic oligodendroglioma (III)). 2 Despite the common occurrence of these tumors in dogs and humans, treatment strategies are rarely curative and survival is poor. 1, 3 MR imaging features may sometimes be a non-invasive surrogate for determining tumor type, especially when biopsy is not feasible. MR imaging is highly specific in differentiating human oligodendroglioma from astrocytoma and often provides information regarding tumor grade. 4 Differentiation between tumor type and grade is important, as survival differs significantly among these groups. 5 Mean survival for human patients with low-grade (II) oligodendroglioma is twice that of patients with lowgrade (II) astrocytoma, and survival for high-grade oligodendrogliomas (III) is over 8 times longer than those with high-grade astrocytoma (IV). 6 Currently these survival data are largely unknown in dogs with astrocytomas or oligodendrogliomas. As attempts are made to determine survival and response of gliomas to current treatments, 3, [7] [8] the need for establishing reliable MR imaging criteria to diagnose and distinguish between tumor types is likely to increase.
The MR criteria for diagnosing human astrocytomas and oligodendrogliomas include location, tissue involvement relative to grey matter, signal intensity and contrast enhancement. 9 Oligodendrogliomas are heterogeneous in signal, typically isointense to grey matter, and are peripheral intra-axial masses. 9 Cortical infiltration and marked cortical thickening is the most useful MR finding relating to the diagnosis of oligodendroglioma. 9 In contrast, astrocytomas arise within white matter and are therefore located more deeply within the hemisphere, are typically T2-hyperintense to grey matter and are usually more homogeneous in signal intensity. Both glioma types may have internal hemorrhage, mineralization, and cystic areas, though cysts are less common in lower grade astrocytomas. 9 Contrast enhancement is common to both and is usually non-uniform. High grade varieties of each tumor type (glioblastoma and anaplastic oligodendroglioma) can be indistinguishable on MR, being highly heterogeneous and having extensive surrounding edema. 9 In dogs, several reports and review articles exist concerning the MR appearance of intracranial glioma. 1, 10, [12] [13] [14] [15] and partially mirror the approach used in people. 9 The limitations of adopting these MR criteria for the dog include the small sample size of existing descriptions 10 , heterogeneous reporting of imaging findings between series, and grouping of tumor type data in some reports [12] [13] 15 . Little information has been included as to the peripheral location of oligodendrogliomas or the presence or absence of cortical thickening.
Our goals were to describe the MR imaging features of histologically confirmed canine intracranial astrocytomas and oligodendrogliomas through a multi-center series and to attempt to differentiate between glial tumor types based on imaging features. We hypothesized that: 1) oligodendrogliomas would be located more peripherally and more commonly contact the meninges, 2) astrocytomas would be located more deeply within the hemispheres and more commonly contact the lateral ventricles or thalamus, 3) signal intensity, the presence of hemorrhage, cystic areas, and contrast enhancement would be similar in both tumor types, 4) perilesional edema would be more common in high grade gliomas, and that 5) lesion burden would not be different between tumor types.
Materials and Methods
This retrospective study was an inter-institutional collaboration. ) and grey or white matter involvement were recorded. Lesion signal characteristics compared to normal grey matter were recorded.
The presence of contrast enhancement was recorded and graded subjectively as mild, moderate, or severe. 10 Evidence of ring-like enhancement and perilesional T2 hyperintensity were noted. Lesion contact with either the meninges or ventricles was recorded. The presence of hemorrhage (determined by a combination of signal intensity on T1/T2-W and corresponding signal void on T2*-gradient recall echo (GRE)), brain herniation (transtentorial or foramen magnum 17 ), and mass effect (deviation of the falx cerebri from midline or compression of the lateral ventricle 18 ) were recorded. The presence of cystic regions within the brain were recorded and defined as lesions being both strongly T1-hypointense and T2-hyperintense with sharply delineated margins on both sequences.
The lesion burden was estimated in 27 of the 30 dogs using a method described previously. 19 In 3 dogs the image files were not compatible with the analysis program.
Regions of interest (ROI) were drawn manually around lesions in every slice on the transverse T2-W to include perilesional edema in estimation of total lesion burden.
Regions of interest were drawn around the entire brain in every slice on the transverse Table 1 . Only one dog in each tumor type had multiple brain lesions; the remainder had only singe lesions. Single tumors which involved more than one brain region appeared to extend continuously from one region to the next. Only three tumors crossed midline; all were astrocytomas (2 medium and 1 high grade).
MR imaging characteristics are summarized in Table 2 . Precontrast tumor appearance is typified in Figure 1 . Twenty-one of twenty-eight dogs given contrast medium had lesion enhancement graded as mild (3 astrocytomas, 6 oligodendrogliomas), moderate (4 astrocytomas, 4 oligodendrogliomas), or strong (3 astrocytomas, 1 oligodendroglioma) ( Figure 3 ). Contrast enhancement was non-uniform in all dogs. Frequency of contrast enhancement was not significantly different between tumor types, but it was significantly more common in high grade tumors (Table 3) . No other features were different between tumor grades (Table 3) . Astrocytomas were typically round or ovoid with defined margins (11/14) ( Figure   1 ). Signal intensity was typically T1-hypointense and T2-hyperintense to grey matter, and most were uniform in intensity prior to contrast enhancement. All but two astrocytomas invaded or effaced both grey and white matter (Figure 1 The material from the 30 dogs in this study was collected from four veterinary teaching hospitals in the continental United States. The breed distribution was consistent with previous reports, with Boxers and Boston Terriers being most frequently affected. 21 Dogs were generally middle age or older adults, typical of glioma patients. 21 There was not a gender over-representation in dogs with glioma, which has been noted previously. 21 All oligodendrogliomas and 12 of 14 astrocytomas involved only the prosencephalon, as expected. 1 While all regions of the prosencephalon contained gliomas, a high proportion of lesions involved the piriform lobe and the adjacent temporal lobe. A tendency for canine glioma to be located in the piriform lobe has been suggested 22 but specific data have not been available previously. Additionally, there was glioma contact with ventricular surfaces in 27 of 30 dogs (Figure 2 ), a feature not reported previously in dogs. The propensity for gliomas to abut the ventricular system and involve the piriform lobe may underscore a potential mechanism of oncogenesis.
Both the subventricular white matter and dentate gyrus, which closely approximates the piriform lobe, contain neural stem cells which may differentiate into gliomas in people and dogs. [23] [24] Tumor involvement of more than one brain region was rare (2/30), as was identification of more than one brain lesion (2/30). Involvement of multiple brain regions has been reported in 79/168 (47%) of canine brain tumors but types other than astrocytoma and oligodendroglioma were included. 1 Only 3 of the 30 tumors presented here crossed midline, and all were astrocytomas. Though it would be reasonable to conclude that astrocytomas should be more extensive and more likely to involve a greater volume of brain, we found no difference in lesion burden between astrocytomas and oligodendrogliomas.
The most common appearance of each tumor type was that of an ovoid or spherical lesion with defined, regular margins. A minority of tumors in each group were amorphous with ill-defined, irregular margins. A mixture of defined and ill-defined lesions has been noted for astrocytomas and oligodendrogliomas. 1, [10] [11] [12] There were no MR features relating to signal intensity or uniformity that were significantly different between astrocytomas and oligodendrogliomas. Gliomas were generally T2-hyperintense and T1-hypointense or isointense, which is non-specific. Ten of 30 tumors had non-uniform pre-contrast signal, which can be associated with hemorrhage, cyst formation, necrosis, altered cellular density, or mineralization. 9 In people, a non-uniform lesion signal intensity is common in oligodendrogliomas and medium and high grade astrocytomas and is associated with the amount of tumor necrosis. 9, 25 Unlike in humans, a non-uniform lesion signal intensity did not add value in predicting tumor type or grade in dogs.
Cystic regions were identified in half of the astrocytomas and more than seventy percent of the oligodendrogliomas. This exceeds the frequency reported previously in canine gliomas. 1, 10, [12] [13] [14] 26 Cystic areas may develop for several reasons, including focal necrosis. 12, 27 MR findings suggestive of necrosis are low T1 signal, high T2 signal and lack of contrast enhancement. 26, 28 The use of T2-FLAIR sequences increases the sensitivity of tumor cyst detection over standard T1/T2-W sequences for lesions containing necrotic, proteinaceous or myxoid material. 29 Tumor cysts may also contain debris, which settles to the dependant portion of the cyst during imaging. 9 Cysts may be distinguished from a necrotic tumor focus by the presence of sharp margins and relatively higher T2 signal. 9, 28, 30 However, while MR imaging is sensitive at detecting cysts and necrosis in dogs with gliomas, it was not sensitive enough to distinguish between them. 12 Regardless of the cause, the identification of cystic regions in an intraaxial brain mass is a feature common to both astrocytomas and oligodendrogliomas in dogs. In contrast to humans, cysts did not occur more commonly in higher grade astrocytomas and was equally common to low grade varieties.
Hemorrhage was identified in 10 of 30 astrocytomas and oligodendrogliomas as a component of the larger mass. Hemorrhage associated with a brain tumor is often the result of necrosis and therefore typically has MR features which differ from benign hemorrhage. 9, 31 Compared to a benign hematoma, tumor-associated hemorrhage often has heterogeneous signal from intermittent bleeding, associated non-hemorrhagic tissue that corresponds to the tumor, delayed hematoma evolution, absent hemosiderin rim and pronounced or persistent edema. 31 Since sequential MR imaging is rare in canine patients, delay of hematoma evolution and prolonged edema can only be estimated using the onset of clinical signs as a temporal reference point. While MR recognition of mineralization has been described in gliomas, 10 the appearance of brain tissue mineralization may be indistinguishable from hemorrhage without advanced MR techniques such as corrected gradient echo phase imaging and susceptibility weighted imaging.
32-33
The attempt to identify mineralization on standard imaging sequences may be of little value in glioma differentiation.
Perilesional T2 hyperintensity was noted in greater than 75% of the astrocytomas and oligodendrogliomas. These results indicate a higher frequency of occurrence in oligodendrogliomas than thought previously. 11 The term perilesional T2-hyperintensity was used instead of edema because in human gliomas, tumor margins often cannot be separated from edema and often exceed the margins established via imaging when evaluated with histopathology. 9, [34] [35] Even with diffusion weighted MR imaging highgrade gliomas cannot be distinguished from surrounding edema. 36 It has been suggested that the region of high T2 signal should be considered as tumor plus edema.
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Perilesional T2-hyperintensity was defined in our study as high T2 signal that appeared more extensive than the size of the mass based on the T1-hypointense region, or region of contrast enhancement. The MR detection of high perilesional T2 signal has been described for both gliomas and meningiomas and was not useful for distinguishing between these tumor types or for differentiating between neoplastic and non-neoplastic diseases in dogs. 15 In human gliomas, the amount of perilesional T2-hyperintensity is one feature used to characterize glioma grade. 9, 25 This MR finding also is used as a prognostic indicator and has been linked to poorer survival in high-grade glioma. [37] [38] Contrary to our hypothesis and to the appearance in humans, we found no significant association between perilesional T2-hyperintensity and grade. The relationship of this finding to survival in dogs has yet to be established.
Lesion contrast enhancement was also present in approximately 75% of astrocytomas and oligodendrogliomas, and ranged from mild to strong. The incidence of ring-like enhancement was not different between the tumor types investigated here and is a non-specific finding common to many intracranial diseases. 1,10-12,39-42 A linear relationship has been established between the degree of contrast enhancement and volume of peritumoral edema in human gliomas. [43] [44] The conclusion was that the same mechanism for breakdown of the blood brain barrier was the cause of both imaging findings. This perhaps explains the high rate of both findings in the tumors described herein. In our analysis, contrast enhancement was more common in higher grade gliomas and was the only feature which was significantly different between high and low grade tumors. This is similar to findings in diffuse astrocytomas in humans. 25 The one feature which was significantly different between astrocytoma and oligodendroglioma was the appearance of tumor contact with the meninges.
Oligodendrogliomas were significantly more likely to contact the brain surface than astrocytomas (P = 0.046). This may reflect a tendency for oligodendrogliomas to invade the brain periphery and meninges, as suggested previously. 22 In humans, one distinguishing feature of adult oligodendroglioma is marked cortical thickening and infiltration. 9 Thickening of the cortex was identified in one tumor in this study, a high grade oligodendroglioma. Histologically, all tumors which invaded the cortex and extended to the meninges appeared as thickened cortex. The smaller brain size and thinner cortex in dogs compared to people may be one explanation for the failure to detect this change. Alternatively the lack of apparent cortical thickening may reflect a difference between the biologic behavior of oligodendroglioma in dogs and people, as all but one oligodendroglioma involved both grey and white matter. It is possible that effacement of the grey-white distinction also obscures expansion of the cortex.
Although astrocytomas occurred more frequently in the diencephalon compared to oligodendrogliomas (57% versus 25%, respectively), this difference was nonsignificant (P = 0.073), perhaps due to the sample size. In necropsy confirmed canine glioma, histologic involvement of the diencephalon was 8 times more likely in astrocytic tumors compared to oligodendroglial tumors. 1 Survival was short for dogs with both glial tumor types, with a median less than 80 days. There was no significant difference in survival or the frequency of survival to discharge between dogs with astrocytoma vs. oligodendroglioma. Fifteen of the patients were euthanized shortly after imaging. Interestingly 10 of the 14 patients that survived to discharge were from the same institution. In fact 100 percent of the cases identified from that institution survived to discharge. These data suggest that clinician philosophy, means of patient follow-up, or research interests in addition to severity of neurologic deficits at the time of diagnosis 3 influence survival time and will complicate the correlation of survival time with tumor type.
Some limitations of our evaluation are as follows. The requirement for biopsy or necropsy confirmation limited the possibility of misclassification but might have causee selection bias if dogs without confirmation were different that those with confirmation.
Imaging protocols were non-uniform and limited data were available on sequence variables but all studies were considered diagnostic. We made no attempt to correlate treatment to survival or the appearance of the tumor in the MR images because treatment data were not collected uniformly and were not available for all dogs. GFAP immunostaining was not available on all dogs. Differentiation between astrocytic and oligodendrocytic tumors can occasionally be difficult when based on H&E morphology alone. Gliomas can be heterogeneous and have features of both astrocytoma and oligodendroglioma. The number of slides examined for each dog was small, and the slides may not have been representative of the entire neoplasm.
There is a need for non-invasive diagnostic criteria to distinguish gliomas from non-neoplastic brain diseases or less aggressive brain neoplasias. As brain biopsy is performed infrequently in dogs, MR imaging features are used commonly to make clinical diagnoses in intracranial disease. In one report, 70% of primary intracranial tumors in dogs could be grouped correctly as meningioma, glioma, choroid plexus papilloma, or ependymoma. 12 However, 10% of the dogs had neoplastic disease which was misdiagnosed as a non-neoplastic process; all misdiagnosed dogs had glioma (3 of 15 total glioma cases). As a non-neoplastic disease comparison group was not included in the study presented here, the misdiagnosis of glial neoplasia might have been minimized artificially, and the accuracy of these MR features for differentiating glioma from non-neoplastic diseases remains unknown.
Based on our findings, a solitary, well defined, contrast enhancing, intra-axial, ovoid, lesion of the prosencephalon with ventricular contact and mass effect are consistent with both astrocytoma or and oligodendroglioma. Ring-like contrast enhancement, perilesional T2-hyperintensity, cystic areas and hemorrhage also are common to both tumors. We did not identify an MR features which allows differentiation between these two tumor types, though oligodendrogliomas contact the peripheral meninges more frequently than do astrocytomas. Contrast enhancement was significantly associated with higher tumor grade.
